Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry

Molecular biology of esophageal adenocarcinoma (EAC) is not fully elucidated. The aim of this study was to assess the expression of cycle regulator and tumor suppressor p16 in esophageal adenocarcinoma. The expression of p16 at protein and gene level was investigated using immunohistochemistry and f...

Full description

Bibliographic Details
Main Authors: Kotzev A., Kamenova M.
Format: Article
Language:English
Published: Sciendo 2017-10-01
Series:Acta Medica Bulgarica
Subjects:
Online Access:https://doi.org/10.1515/amb-2017-0013
_version_ 1819203266364309504
author Kotzev A.
Kamenova M.
author_facet Kotzev A.
Kamenova M.
author_sort Kotzev A.
collection DOAJ
description Molecular biology of esophageal adenocarcinoma (EAC) is not fully elucidated. The aim of this study was to assess the expression of cycle regulator and tumor suppressor p16 in esophageal adenocarcinoma. The expression of p16 at protein and gene level was investigated using immunohistochemistry and fluorescence in situ hybridization in thirteen EAC specimens obtained by endoscopic biopsies and surgical resections. The mean age of enrolled patients was 62 years and a male predominance was observed. Loss of p16 protein expression was detected in 77% of the cases and loss of p16 gene was found in 69% of cases as hemizygous deletion was the most common. Significant correlation was found between the absence of p16 protein expression and p16 allelic loss. Cell cycle disturbances seem to play role in the EAC carcinogenesis and probably p16 gene deletions are connected with the loss of p16 protein expression.
first_indexed 2024-12-23T04:17:11Z
format Article
id doaj.art-b3cda9adbbb74db3bbeaed71d44324a6
institution Directory Open Access Journal
issn 0324-1750
language English
last_indexed 2024-12-23T04:17:11Z
publishDate 2017-10-01
publisher Sciendo
record_format Article
series Acta Medica Bulgarica
spelling doaj.art-b3cda9adbbb74db3bbeaed71d44324a62022-12-21T18:00:22ZengSciendoActa Medica Bulgarica0324-17502017-10-01442141910.1515/amb-2017-0013amb-2017-0013Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and ImmunohistochemistryKotzev A.0Kamenova M.1Department of Propedeutics of Internal Diseases, Medical University – Sofia, BulgariaDepartment of Clinical Pathology, University Hospital “Pirogov” – Sofia, BulgariaMolecular biology of esophageal adenocarcinoma (EAC) is not fully elucidated. The aim of this study was to assess the expression of cycle regulator and tumor suppressor p16 in esophageal adenocarcinoma. The expression of p16 at protein and gene level was investigated using immunohistochemistry and fluorescence in situ hybridization in thirteen EAC specimens obtained by endoscopic biopsies and surgical resections. The mean age of enrolled patients was 62 years and a male predominance was observed. Loss of p16 protein expression was detected in 77% of the cases and loss of p16 gene was found in 69% of cases as hemizygous deletion was the most common. Significant correlation was found between the absence of p16 protein expression and p16 allelic loss. Cell cycle disturbances seem to play role in the EAC carcinogenesis and probably p16 gene deletions are connected with the loss of p16 protein expression.https://doi.org/10.1515/amb-2017-0013esophageal adenocarcinomap16immunohistochemistryfluorescence in situ hybridization
spellingShingle Kotzev A.
Kamenova M.
Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
Acta Medica Bulgarica
esophageal adenocarcinoma
p16
immunohistochemistry
fluorescence in situ hybridization
title Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
title_full Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
title_fullStr Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
title_full_unstemmed Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
title_short Loss of P16 in Esophageal Adenocarcinoma Detected by Fluorescence in situ Hybridization and Immunohistochemistry
title_sort loss of p16 in esophageal adenocarcinoma detected by fluorescence in situ hybridization and immunohistochemistry
topic esophageal adenocarcinoma
p16
immunohistochemistry
fluorescence in situ hybridization
url https://doi.org/10.1515/amb-2017-0013
work_keys_str_mv AT kotzeva lossofp16inesophagealadenocarcinomadetectedbyfluorescenceinsituhybridizationandimmunohistochemistry
AT kamenovam lossofp16inesophagealadenocarcinomadetectedbyfluorescenceinsituhybridizationandimmunohistochemistry